A
Alan J. Gelenberg
Researcher at University of Arizona
Publications - 126
Citations - 9775
Alan J. Gelenberg is an academic researcher from University of Arizona. The author has contributed to research in topics: Major depressive disorder & Placebo. The author has an hindex of 46, co-authored 126 publications receiving 9341 citations. Previous affiliations of Alan J. Gelenberg include Rosalind Franklin University of Medicine and Science & Harvard University.
Papers
More filters
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Journal ArticleDOI
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
Martin B. Keller,James P. McCullough,Daniel N. Klein,Bruce A. Arnow,David L. Dunner,Alan J. Gelenberg,John C. Markowitz,Charles B. Nemeroff,James M. Russell,Michael E. Thase,Madhukar H. Trivedi,John Zajecka +11 more
TL;DR: Although about half of patients with chronic forms of major depression have a response to short-term treatment with either nefazodone or a cognitive behavioral-analysis system of psychotherapy, the combination of the two is significantly more efficacious than either treatment alone.
Journal ArticleDOI
The Arizona Sexual Experience Scale (ASEX): reliability and validity.
Cynthia A. McGahuey,Alan J. Gelenberg,C. Laukes,Francisco A. Moreno,Pedro L. Delgado,Kathy M. McKnight,Rachel Manber +6 more
TL;DR: The authors have developed the Arizona Sexual Experiences Scale (ASEX), a five-item rating scale that quantifies sex drive, arousal, vaginal lubrication/penile erection, ability to reach orgasm, and satisfaction from orgasm.
Journal ArticleDOI
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
A. John Rush,Helena C. Kraemer,Harold A. Sackeim,Maurizio Fava,Madhukar H. Trivedi,Ellen Frank,Philip T. Ninan,Michael E. Thase,Alan J. Gelenberg,David J. Kupfer,Darrel A. Regier,Jerrold F. Rosenbaum,Oakley S. Ray,Alan F. Schatzberg +13 more
TL;DR: Recommendations suggest that symptom ratings that measure all nine criterion symptom domains to define a major depressive episode are preferred as they provide a more certain ascertainment of remission.
Journal ArticleDOI
Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder.
Alan J. Gelenberg,John M. Kane,Martin B. Keller,Philip W. Lavori,Jerrold F. Rosenbaum,Karyl Cole,Janet Lavelle +6 more
TL;DR: D doses resulting in serum lithium levels from 0.8 to 1.0 mmol per liter are more effective in treating bipolar disorder than those that result in lower serum lithium concentrations, although the higher doses are associated with a higher incidence of side effects.